Blog

RETOS 2017

Retos Colaboration 2017 project completion

Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer  in a blood sample. The Aniling -led project uses patented GEUS …

ERIC 2022

Aniling in the ERIC International Meeting 2022

This week Aniling is attending the ERIC | European Research Initiative on CLL International Meeting in Barcelona focused on Chronic Lymphocytic Leukemia (CLL) as a paradigmatic disease for realizing the concepts of precision medicine towards improving …

Aniling Management

Farmabiotec reports Aniling achievements

The health biotechnology magazine Farmabiotec reports on Aniling’s late achivements. Farmabiotec goes through Aniling’s IVD tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy and highlights their recent CE …

World CLL Day

World CLL Day 2022

Every 1 September, the global CLL community unites to raise awareness about chronic lymphocytic leukemia (CLL) and give those affected by a diagnosis of CLL a much needed voice. On …

Aniling in Expansion

Expansion reports Aniling achievements

Expansión newspaper explains the company’s latest milestone: Aniling obtains CE marking for three in vitro tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. News written by Gabriel Trindade …

Aniling BBQ2022

Aniling participates in BBQ2022

Last week, Aniling participated in the BBQ2022 organized by CataloniaBio & HealthTech. After the obliged pause due to the COVID-19 pandemic, the BBQ welcomed nearly 400 professionals looking to meet …